Hypertriglyceridemia Clinical Trials

233 clinical trials for Hypertriglyceridemia across international registries, including 25 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Long-Term Safety and Efficacy of Plozasiran in Adults With Hypertriglyceridemia — RECRUITING · PHASE3
• Study of MAR001 in Adults With Elevated Triglycerides and Remnant Cholesterol — RECRUITING · PHASE2
• A Safety and Tolerability Trial Evaluating CTX310 in Participants With Refractory Dyslipidemias — RECRUITING · PHASE1
• Phase 1b Study of VERVE-201 in Patients With Refractory Hyperlipidemia — RECRUITING · PHASE1
• A Study to Assess the Safety, Tolerability and Efficacy of ION775 — RECRUITING · PHASE2
• A Trial to Evaluate the Efficacy and Safety of DR10624 in Patients With Hypertriglyceridemia and Carotid Atherosclerotic Plaque — RECRUITING · NA
• A Study of SHR-1918 In Participants With Hypertriglyceridemia — RECRUITING · PHASE3
• RBD5044 in Chinese Participants With Hypertriglyceridemia — RECRUITING · PHASE2
• Effect of Consuming n-3 Polyunsaturated Fatty Acids Rich Foods on Triglyceride Concentration and Lipoprotein Composition — RECRUITING · NA
• Russian Extreme Hypertriglyceridemia Registry — RECRUITING
• A PHASE 2, OPEN-LABEL TRIAL EVALUATING THE SAFETY, TOLERABILITY AND EFFICACY OF ION775 IN ADULTS WITH HYPERTRIGLYCERIDEMIA — RECRUITING · PHASE2
• Metabolic Heterogeneity Underlying Hypertriglyceridemia: Hepatic Triglyceride Biosynthesis in Humans With Different Insulin Resistance Phenotypes — RECRUITING · NA
• a Phase 1b/2a Study of JMT202 Injection in Participants With Hypertriglyceridemia — RECRUITING · PHASE1
• A PHASE 2, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO INVESTIGATE THE EFFICACY AND SAFETY OF LY3561774 (SOLBINSIRAN) IN ADULTS WITH SEVERE HYPERTRIGLYCERIDEMIA (SOLARIS-1) — RECRUITING · PHASE2
• A Mechanistic Study of MAR001 in Adults With Elevated Triglycerides and Remnant Cholesterol — RECRUITING · PHASE2
• Interest of High-speed Centrifugation for Measuring Anti-Xa Activity on Lipemic Plasma — RECRUITING
• Differential Thrombogenesis by EPA and DHA Mediated by HDL — RECRUITING · PHASE1
• Vitamin C Administration and Triglycerides Level in Critical Care Patients — RECRUITING
• Phase 2a Study of Safety, Tolerability, and Efficacy of TLC-2716 in Subjects With Hypertriglyceridemia and NAFLD — RECRUITING · PHASE2
• A PHASE 3 OPEN-LABEL EXTENSION STUDY TO EVALUATE THE LONG-TERM SAFETY AND EFFICACY OF PLOZASIRAN IN ADULTS WITH HYPERTRIGLYCERIDEMIA (SHASTA-10 STUDY) — RECRUITING · PHASE3
• DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE 3 STUDY TO EVALUATE THE EFFICACY AND SAFETY OF PLOZASIRAN IN ADULTS WITH SEVERE HYPERTRIGLYCERIDEMIA (SHASTA-3 STUDY) — RECRUITING · PHASE3
• A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF PEGOZAFERMIN IN SUBJECTS WITH SEVERE HYPERTRIGLYCERIDEMIA (SHTG — RECRUITING · PHASE3
• AN OPEN-LABEL EXTENSION STUDY OF OLEZARSEN (ISIS 678354) ADMINISTERED SUBCUTANEOUSLY TO PATIENTS WITH SEVERE HYPERTRIGLYCERIDEMIA (SHTG) — RECRUITING
• A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, DOSE-RANGING PHASE 2 STUDY OF ISIS 678354 ADMINISTERED SUBCUTANEOUSLY TO PATIENTS WITH HYPERTRIGLYCERIDEMIA AND ESTABLISHED CARDIOVASCULAR DISEASE (CVD) — RECRUITING · PHASE2
• A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PILOT STUDY TO ASSESS THE SAFETY, EFFICACY AND PHARMACODYNAMICS OF CAT-2003 ALONE AND IN COMBINATION WITH A STATIN IN PATIENTS WITH HYPERLIPIDEMIA (PATHWAYS I) — RECRUITING
• A double-blind, placebo-controlled, intervention trial comparing the triglyceride-lowering effect of omega-3 polyunsaturated fatty acids, as either ethyl ester or triglycerides in patients with moderately elevated triglyceride levels in the blood in non fasting state. — COMPLETED · PHASE4
• Nutritional Transitions to More Plant Proteins and Less Animal Proteins: Understanding the Induced Metabolic Reorientations and Searching for Their Biomarkers (ProVegOmics) — COMPLETED · NA
• A Phase III Study to Evaluate the Efficacy and Safety of of DR10624 in Subjects With Severe Hypertriglyceridemia — NOT_YET_RECRUITING · PHASE3
• Phase 3 Study of Plozasiran in Adults With Hypertriglyceridemia — ACTIVE_NOT_RECRUITING · PHASE3
• Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Plozasiran in Adults with Hypertriglyceridemia (MUIR-3 Study) — TERMINATED · PHASE3
• GLP-1 Agonists for Prevention of Recurrent Hypertriglyceridemic Acute Pancreatitis — NOT_YET_RECRUITING · PHASE4
• DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE 3 STUDY TO EVALUATE THE EFFICACY AND SAFETY OF PLOZASIRAN IN ADULTS WITH SEVERE HYPERTRIGLYCERIDEMIA AT HIGH RISK OF ACUTE PANCREATITIS (SHASTA-5 STUDY) — NOT_YET_RECRUITING · PHASE3
• WB-EMS Effects on Cardiometabolic Risk Factors — ACTIVE_NOT_RECRUITING · NA
• A PHASE 3 OPEN-LABEL EXTENSION STUDY TO EVALUATE THE LONG-TERM SAFETY AND EFFICACY OF PLOZASIRAN IN ADULTS WITH HYPERTRIGLYCERIDEMIA (SHASTA-10 STUDY) — TERMINATED · PHASE3
• A Study of Olezarsen (Formerly Known as AKCEA-APOCIII-LRx) in Adults With Hypertriglyceridemia and Atherosclerotic Cardiovascular Disease (Established or at Increased Risk for), and/or With Severe Hypertriglyceridemia — COMPLETED · PHASE2
• Single-ascending Dose Study of Kylo-12 in Healthy Subjects — ACTIVE_NOT_RECRUITING · PHASE1
• A Study of Olezarsen (ISIS 678354) in Participants With Hypertriglyceridemia and Atherosclerotic Cardiovascular Disease, or With Severe Hypertriglyceridemia — COMPLETED · PHASE3
• MN-001 in Non-alcoholic Fatty Liver Disease, Type 2 Diabetes Mellitus, and Hypertriglyceridemia — ACTIVE_NOT_RECRUITING · PHASE2
• Study of RN0361in Adult Healthy Subjects and Adult Hypertriglyceridemic Subjects — ACTIVE_NOT_RECRUITING · PHASE1
• Study of ARO-ANG3 in Healthy Volunteers and in Dyslipidemic Patients — COMPLETED · PHASE1
• Study of ARO-APOC3 in Healthy Volunteers, Hypertriglyceridemic Patients and Patients With Familial Chylomicronemia Syndrome (FCS) — COMPLETED · PHASE1
• Efficacy and Safety of Cipros 10 Association on the Isolated Hypertriglyceridemia and Dyslipidemia Treatment — COMPLETED · PHASE3
• Study of MAR001 in Adults With Metabolic Dysfunction — COMPLETED · PHASE1
• Response to an Intervention With Omega-3 (RIO - Study) — COMPLETED · NA
• A VSA003 Phase 1 Study in Chinese Adult Healthy Volunteers — COMPLETED · PHASE1
• Evaluation of the Efficacy of Phospholipid-Bound Omega-3 Versus Omega-3 Alone in Patients With Hypertriglyceridemia: A Randomized Clinical Trial — ACTIVE_NOT_RECRUITING · NA
• A Study of LY3875383 in Healthy Participants and Participants With Hypertriglyceridemia — TERMINATED · PHASE1
• Cardiometabolic Properties of Omega-3 Functionalized With Hydroxytyrosol — ACTIVE_NOT_RECRUITING · NA
• Barberry and Cardiometabolic Risk Factors in Individuals With Hypertriglyceridemia — COMPLETED · NA
• Effects of DHA-NAT on Postprandial Lipidaemia in Healthy Male Subjects — ACTIVE_NOT_RECRUITING · NA

Refine this search